FDA inspection
GlaxoSmithKline Biologicals Kft.: FDA inspection ending Jan 31, 2025
FDA inspection 1259740 · Voluntary Action Indicated (VAI) · Godollo
Key facts
| Inspection ID | 1259740 |
|---|---|
| Firm | GlaxoSmithKline Biologicals Kft. |
| FEI number | 3008322822 |
| Address | Homoki Nagy Istvan Utca 1 |
| City | Godollo |
| Country | Hungary |
| Fiscal year | 2025 |
| Inspection end date | Jan 31, 2025 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Vaccines and Allergenic Products |
| Product type | Biologics |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data